Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program
- PMID: 26411977
- PMCID: PMC4731047
- DOI: 10.1007/s10557-015-6619-0
Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program
Abstract
Introduction: Initiation of class III anti-arrhythmic medications requires telemetric monitoring for ventricular arrhythmias and QT prolongation to reduce the risk of torsades de pointes (TdP). Heart rate-corrected QT interval (QTc) is an indicator of risk, however it is imperfect, and subtle abnormalities of repolarization have been linked with arrhythmogenesis.
Purpose: Identification of electrocardiographic predictors of torsadogenic risk through the application of a novel T wave analysis tool.
Methods: Among all patients admitted to Mayo Clinic for initiation of dofetilide or sotalol, we identified 13 cases who developed drug-induced TdP and 26 age and sex matched controls that did not develop TdP. The immediate pre-TdP ECG of those with TdP was compared to the last ECG performed prior to hospital discharge in controls using a novel T wave program that quantified subtle changes in T wave morphology.
Results: The QTc and 12 T wave parameters successfully distinguished TdP cases from controls. The top performing parameters were the QTc in lead V3 (mean case vs control 480 vs 420 msec, p < 0.001, r = 0.72) and T wave right slope in lead I (mean case vs control -840.29 vs -1668.71 mV/s, p = 0.002, r = 0.45). The addition of T wave right slope to QTc improved prediction accuracy from 79 to 88 %.
Conclusion: Our data demonstrate that, in addition to QTc, the T wave right slope is correlated strongly with TdP risk. This suggests that a computer-based repolarization measurement tool that integrates additional data beyond the QTc may identify patients with the greatest torsadogenic potential.
Keywords: Class III antiarrhythmics; Electrocardiography; Risk stratification; T wave analysis; Torsade de pointes.
Figures





Comment in
-
T-wave Right Slope Provides a New Angle in the Prediction of Drug-Induced Ventricular Arrhythmias : Editorial to: "Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program" by Sugrue A. et al.Cardiovasc Drugs Ther. 2015 Oct;29(5):411-3. doi: 10.1007/s10557-015-6620-7. Cardiovasc Drugs Ther. 2015. PMID: 26438190 No abstract available.
Similar articles
-
Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.J Interv Card Electrophysiol. 2019 Mar;54(2):189-196. doi: 10.1007/s10840-018-0476-2. Epub 2018 Oct 23. J Interv Card Electrophysiol. 2019. PMID: 30353374
-
Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.J Clin Pharmacol. 2009 Jan;49(1):6-16. doi: 10.1177/0091270008325927. Epub 2008 Oct 28. J Clin Pharmacol. 2009. PMID: 18957528 Clinical Trial.
-
Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):438-443. doi: 10.1177/1074248420921740. Epub 2020 Apr 29. J Cardiovasc Pharmacol Ther. 2020. PMID: 32347108
-
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.Pharmacotherapy. 2007 Sep;27(9):1297-305. doi: 10.1592/phco.27.9.1297. Pharmacotherapy. 2007. PMID: 17723083 Review.
-
Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.Indian Heart J. 2014 Nov-Dec;66(6):640-8. doi: 10.1016/j.ihj.2013.12.021. Epub 2014 Jan 7. Indian Heart J. 2014. PMID: 25634399 Free PMC article. Review.
Cited by
-
Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st century.J Physiol. 2016 Dec 1;594(23):6893-6908. doi: 10.1113/JP272015. Epub 2016 Jun 9. J Physiol. 2016. PMID: 27060987 Free PMC article.
-
Applications of machine learning in decision analysis for dose management for dofetilide.PLoS One. 2019 Dec 31;14(12):e0227324. doi: 10.1371/journal.pone.0227324. eCollection 2019. PLoS One. 2019. PMID: 31891645 Free PMC article.
-
Automated T-wave analysis can differentiate acquired QT prolongation from congenital long QT syndrome.Ann Noninvasive Electrocardiol. 2017 Nov;22(6):e12455. doi: 10.1111/anec.12455. Epub 2017 Apr 21. Ann Noninvasive Electrocardiol. 2017. PMID: 28429460 Free PMC article.
-
Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.PLoS One. 2016 Dec 6;11(12):e0167348. doi: 10.1371/journal.pone.0167348. eCollection 2016. PLoS One. 2016. PMID: 27923051 Free PMC article.
-
Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review.Eur J Clin Pharmacol. 2022 May;78(5):765-779. doi: 10.1007/s00228-022-03285-3. Epub 2022 Feb 14. Eur J Clin Pharmacol. 2022. PMID: 35156131 Free PMC article.
References
-
- Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012;125(2):381–389. - PubMed
-
- Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Journal of the American College of Cardiology. 2010;55(9):934–947. - PMC - PubMed
-
- Lehmann MH, Hardy S, Archibald D, quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation. 1996;94(10):2535–2541. - PubMed
-
- Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. The American journal of cardiology. 1990;65(2):74A–81A. discussion 2A–3A. - PubMed
-
- Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. The New England journal of medicine. 1999;340(24):1855–1862. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources